Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
  1. 4 Grant or award Chief Executive Officer acquired 5,981 shares (grant or award)
  2. EFFECT Other Notice of Effectiveness
  3. 8-K Event Other events
  4. 424B5 Offering Prospectus
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Grant or award Chief Executive Officer acquired 6,802 shares (grant or award)
  9. UPLOAD Other SEC-generated Letter
  10. S-3 Offering Registration Statement
  11. 4 Grant or award Chief Executive Officer acquired 7,186 shares (grant or award)
  12. 4 Grant or award Director acquired 11,000 shares (grant or award)
  13. 4 Grant or award Director acquired 11,000 shares (grant or award)
  14. 4 Grant or award Director acquired 20,001 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 270,844 shares (grant or award)
  16. 4 Grant or award Director acquired 20,001 shares (grant or award)
  17. 4 Grant or award Director acquired 11,000 shares (grant or award)
  18. 4 Grant or award President acquired 207,201 shares (grant or award)
  19. 4 Grant or award Chief Financial Officer acquired 65,000 shares (grant or award)
  20. 4 Grant or award Director acquired 5,501 shares (grant or award)

Page 5 of 38 · 753 filings